Progress and Limitations of Surgery in Improving Outcomes of Esophagogastric Junction Cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
TO THE EDITORS:
Adenocarcinoma of the esophagogastric junction (EGJ), also called gastric cardia cancer, has attracted major renewed interest from Western surgeons, oncologists, and physicians; statistics show a trend toward an increase in incidence of EGJ cancer, while distal stomach cancer rate is decreasing, prognosis still remains poor, surgeon volume and hospital volume may affect oncological outcomes, and treatment strategy regarding surgery and adjuvant treatment between cardia and noncardia gastric cancer differs.1–4
In a recent issue of the Annals of Surgical Oncology, Carboni and colleagues report on the surgical results of an abdominal-transhiatal approach of Italian patients with EGJ cancer.5 The authors conclude that abdominal-transhiatal approach for Siewert type II and III cardia adenocarcinoma is a safe surgical procedure enabling a complete resection (R0). Despite its strengths, this study has several weaknesses, on which we would like to comment.
Solid evidence from larg ...
- Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90(3):139–46; discussion 146. CrossRef
- Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol. 2002 Nov;9(9):828–30. CrossRef
- Roukos DH, Paraschou P, Lorenz M. Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol. 2000;7(10):719–26. CrossRef
- Liakakos T, Roukos DH. More controversy than ever – challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol. 2008;15(4):956–60. CrossRef
- Carboni F, Lorusso R, Santoro R, Lepiane P, Mancini P, Sperduti I, et al. Adenocarcinoma of the Esophagogastric Junction: The Role of Abdominal-Transhiatal Resection. Ann Surg Oncol. 2009;16(2):304–10. CrossRef
- Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer. 2001;84(12):1602–9. CrossRef
- Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8(5):587–97. CrossRef
- Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26(26):4360–1. CrossRef
- Sasako M, Sano T, Yamamoto S, et al. for Japan Clinical Oncology Group D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62. CrossRef
- Roukos DH. 21-gene assay: Challenges and promises in translating personal genomics and whole genome scans into personalized treatment of breast cancer. J Clin Oncol. (in press).
- Roukos DH. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008;358(15):1636.
- Ziogas D, Baltogiannis G, Fatouros M, et al. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg. 2008;247(4):714–5. CrossRef
- Roukos DH. Assessing both genetic variation (SNPs/CNVs) and interactions with the environment may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009;9(1):1–6. CrossRef
- Roukos DH. Linking contralateral breast cancer with genetics. Radiother Oncol. 2008;86:139–41. CrossRef
- Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2008;15(1):21–33. CrossRef
- Roukos DH. Radiation therapy for breast cancer. N Engl J Med. 2009;360(13):1362–3. CrossRef
- Roukos DH. Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol. 2009;16(4):795–8. CrossRef
- Roukos DH. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol.2009;16(3):772–3. CrossRef
- Progress and Limitations of Surgery in Improving Outcomes of Esophagogastric Junction Cancer
Annals of Surgical Oncology
Volume 16, Issue 7 , pp 2074-2075
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors